This is the authors' abstract. We don't add key points for this paper.
Background: To evaluate the clinical outcome and complications of limb malignant tumors treated with intercalary resection and frozen autograft reconstruction.Methods: We reviewed 40 patients whose malignant bone tumors were treated by wide resection and recycling liquid nitrogen-treated autograft reconstruction between 2006 and 2017. Limb function, bone union at the osteotomy site and complications were evaluated. Functional outcome was assessed using the Musculoskeletal Tumor Society (MSTS) scoring system.Results: The most common tumor was osteosarcoma (11 cases), followed by Ewing’s sarcoma (7 cases). Tumors were located in the humerus (5), ulna (1), femur (13) and tibia (21). The mean follow-up period was 48.4 months (range 11-127 months). Of the 40 patients, 19 remained disease-free, and 3 were alive with disease. The mean size of the defect after tumor resection was 12.1 cm (range 5-24 cm). Bone union was achieved in 37 patients, with a mean union time of 8.7 months (range 4-18 months). Fifteen complications were encountered in 14 patients, including 3 graft nonunions, 3 infections (1 superficial, 2 deep infections), 4 limb length discrepancies, 2 graft fractures and 3 local recurrences. The mean MSTS score was 82.5% (range 50-100%). Excellent functional results were achieved in 24 patients (60%) and good results in 14 (35%).Conclusions: Liquid nitrogen-treated tumor-bearing autografts are a simple and effective option for biologic reconstructions after meta-/diaphyseal tumor resection of long bones. This method has excellent clinical outcomes and is especially recommended for patients with nonosteolytic primary or secondary bone tumors.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2022) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: